To establish whether urinary RKIP could successfully identify LC patients, we first analyzed RKIP levels in urine samples from early-stage lung cancer patients matched with a high-risk control (HR-HS group). This evidence concerns the gene PEBP1 and laryngotracheoesophageal cleft.